Serum Fructosamine and Glycosylated Haemoglobin in Diabetic Subjects and their Non-Diabetic First-Degree Relatives
Aarti Sati1★, Amit Varma2, Neeraj Kumar1, Tariq Masood3, Milan Prabhakar4★ Corresponding author
- 1Department of Pharmacology, School of Pharmaceutical Sciences, Shri Guru Ram Rai University, Patel Nagar, Dehradun, Uttarakhand, INDIA.
- 2Department of Medicine, Shri Guru Ram Rai Institute of Medical and Health Sciences, Shri Guru Ram Rai University, Patel Nagar, Dehradun, Uttarakhand, INDIA.
- 3Department of Biochemistry, Shri Guru Ram Rai Institute of Medical and Health Sciences, Shri Guru Ram Rai University, Patel Nagar Dehradun, Uttarakhand, INDIA.
- 4Department of Pharmacy Practice, School of Pharmaceutical Sciences, Shri Guru Ram Rai University, Patel Nagar, Dehradun, Uttarakhand, INDIA.
CORRESPONDENCE
Aarti Sati
Department of Pharmacology, School of Pharmaceutical Sciences, Shri Guru Ram Rai University, Patel Nagar, Dehradun, Uttarakhand, INDIA.
Received: 02-01-2024; Revised: 04-02-2024; Accepted: 14-03-2024.
Volume 16, Issue 2 · pp. 308–314 · PUBLISHED · DOI: 10.5530/jyp.2024.16.39
ABSTRACT
Aim:To Assess Serum fructosamine and glycosylated haemoglobin in diabetic subjects and their non-diabetic first-degree relatives, a comparative evaluation. Background:Glycosylated Hemoglobin has been used for decades for the diagnosis of diabetes. However, it is altered in situations including red blood cell wall defects, hemoglobinopathies and chronic renal failure. Therefore, the utility of short-term glycemic markers like serum fructosamine is gaining popularity. Objectives:The objective of this research is to assess Serum fructosamine levels in patients with Type II diabetes and their non-diabetic first-degree relatives. Materials and Methods:This research enrolled 300 participants. Group A comprised 100 diabetic patients, Group B contained 100 non-diabetic first-degree relatives (test group) of type II diabetic patients and 100 healthy controls with no immediate family history of Diabetes Mellitus were included in Group C. Results:Fasting blood sugar, postprandial sugar, glycosylated hemoglobin, serum fructosamine levels and fasting insulin levels were tested in each case. The Serum Fructosamine levels (362.95±71.06 μmol/L) and HbA1c (8.59±1.99%) were raised in diabetes patients. The fasting blood sugar and postprandial blood glucose and glycated hemoglobin levels were within the target levels in the first-degree relatives. There is a noteworthy difference in serum fructosamine levels between test and controls at p<0.05. Conclusion:Serum fructosamine can be used as a more robust marker than glycated hemoglobin for the early detection of diabetes in firstdegree relatives.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sati, A., Varma, A., Kumar, N., Masood, T., & Prabhakar, M. (). Serum Fructosamine and Glycosylated Haemoglobin in Diabetic Subjects and their Non-Diabetic First-Degree Relatives. Journal of Young Pharmacists, 16(2), 308–314. https://doi.org/10.5530/jyp.2024.16.39
